Conviction
1 → 3
Conviction●●●○○3 of 5
Research target$462.73Snapshot target
Thesis statusINTACTLast reviewed 7/8/26
Market cap$36.81BSnapshot value
Research history
See all WAT changes ↗What changed
Target
— → $462.73
Thesis status
NEEDS_MORE_DATA → INTACT
Last reviewed
Not reviewed → 7/8/26
Target
— → $462.73
Chromatography + mass spectrometry pure-play. Absorbing BD Biosciences (~$17.5B) — scale compounding. Application-specific columns create recurring consumable lock-in.
BD Biosciences integration ($17.5B acquisition); precision medicine driving instrument demand; consumable pull-through from growing installed base.
Integration execution risk (BD Biosciences); instrument cycle lumpiness; competitive pressure from Thermo/Agilent/Shimadzu.
needs X/Reddit sentiment sweep
Snapshot · 7/8/26🟢 Confirmed ⚡ · ins+$0.5M(2buy👥) · 13F 21+/4- · short↑0.37
Snapshot · 7/8/26